futurethink documents

Cracking the Code of Effective Innovation
Documents Cracking the Code of Effective Innovation
Innovating in Good Times & in Bad
Business Innovating in Good Times & in Bad
Innovator Interview: Sandy Sanzero, Sandia National Laboratories
Business Innovator Interview: Sandy Sanzero, Sandia National Laboratories
futurethink: Future of Social Networks
Business futurethink: Future of Social Networks
Innovator Interview: Amanda West, Thomson Reuters
Business Innovator Interview: Amanda West, Thomson Reuters
The Future of Learning & Development
Business The Future of Learning & Development
Innovator Interview: Randy Voss, Whirlpool
Business Innovator Interview: Randy Voss, Whirlpool
Inno
Documents Inno
Innovator Interview: Daryl Dunbar, Reed Elsevier
Business Innovator Interview: Daryl Dunbar, Reed Elsevier
Innovator Interview: Craig Libby, Wachovia
Business Innovator Interview: Craig Libby, Wachovia
Innovator Interview: Tony
Documents Innovator Interview: Tony
Innovator Interview: Mehmood Khan, Unilever
Business Innovator Interview: Mehmood Khan, Unilever
The Future of Green Business Strategy
News & Politics The Future of Green Business Strategy
Innovator Interview: Anne Carullo, Estee Lauder
Documents Innovator Interview: Anne Carullo, Estee Lauder
Innovator Interview: Mark Hausfeld, Procter & Gamble
Documents Innovator Interview: Mark Hausfeld, Procter & Gamble
Cracking the Code of Effective Innovation
Documents Cracking the Code of Effective Innovation
Innovator Interview: Daryl Dunbar, Reed Elsevier
Documents Innovator Interview: Daryl Dunbar, Reed Elsevier
2008 Innovation Tracker: Ready, Fire! Aim? Why a Fear of Commitment is Killing Innovation
Documents 2008 Innovation Tracker: Ready, Fire! Aim? Why a Fear of Commitment is Killing Innovation
Innovator Interview: Randy Voss, Whirlpool
Documents Innovator Interview: Randy Voss, Whirlpool
Innovator Interview: Craig Libby, Wachovia
Documents Innovator Interview: Craig Libby, Wachovia
Innovator Interview: Rob Spencer, Pfizer
Documents Innovator Interview: Rob Spencer, Pfizer